Kai Wu

Kai Wu is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as a Director at Johnson & Johnson since February 2015. In this role, Kai Wu manages multiple projects involving collaboration with contract research organizations (CROs) to deliver substantial quantities of active pharmaceutical ingredients (APIs) for preclinical studies and clinical trials, while focusing on safety and quality. Previous positions include Director at Hengkang Medical Group, where Kai Wu built and led teams for drug discovery projects, and Assistant Director at ChemPartner, overseeing a large team in the development of synthetic processes. Earlier experience as a Research Scientist at Oakwood Chemical involved the preparation of numerous pharmaceutical intermediates and large-scale projects, complemented by postdoctoral research at the University of Florida in organic and polymer chemistry. Kai Wu holds a Ph.D. in Organic Chemistry from the Shanghai Institute of Organic Chemistry.